LSI

Life Storage, Inc. Announces Date and Time of 1st Quarter Earnings Release and Conference Call

Retrieved on: 
Wednesday, April 12, 2023
Other Consumer, Commercial Building & Real Estate, Construction & Property, Finance, Seniors, Banking, REIT, Professional Services, Consumer, Telephone, Webcast, Storage, PIN, Life Storage, NYSE, LSI, Cryptocurrency

The Company will conduct a conference call to discuss operations and review financial results on Wednesday, May 3, 2023 at 9:00 a.m. Eastern Time.

Key Points: 
  • The Company will conduct a conference call to discuss operations and review financial results on Wednesday, May 3, 2023 at 9:00 a.m. Eastern Time.
  • The Company encourages pre-registration for the telephone conference to help avoid connection delays.
  • Participants may use this link to pre-register and receive a dial-in number and unique PIN.
  • Participants who are unable to pre-register may access the conference call by dialing 888.506.0062 (domestic), or 973.528.0011 (international); passcode 444471 or request to be joined into the Life Storage call.

Life Storage, Inc. Announces Dividend on Common Stock

Retrieved on: 
Monday, April 3, 2023
Commercial Building & Real Estate, Seniors, Construction & Property, Finance, Banking, Professional Services, REIT, Consumer, Life Storage, NYSE, LSI, Holding company, Real estate

The Board of Directors of Life Storage, Inc. (NYSE:LSI), a self-storage real estate investment trust (REIT), announced today the Company’s quarterly dividend of $1.20 per share of common stock.

Key Points: 
  • The Board of Directors of Life Storage, Inc. (NYSE:LSI), a self-storage real estate investment trust (REIT), announced today the Company’s quarterly dividend of $1.20 per share of common stock.
  • The annualized dividend of Life Storage, Inc. is $4.80 per share that, based on today’s opening share price, equates to an annual yield of approximately 3.6%.
  • The dividend will be paid on April 26, 2023 to Shareholders of record on April 14, 2023.

LSI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Life Storage, Inc. Is Fair to Shareholders

Retrieved on: 
Monday, April 3, 2023
Legal, Professional Services, Sale, Life, Life Storage, Fraud, NYSE, Self storage, Advertising, LSI

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Life Storage, Inc. (NYSE: LSI) to Extra Space Storage Inc. for 0.8950 Extra Space shares for each Life Storage share is fair to Life Storage shareholders.

Key Points: 
  • Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Life Storage, Inc. (NYSE: LSI) to Extra Space Storage Inc. for 0.8950 Extra Space shares for each Life Storage share is fair to Life Storage shareholders.
  • At closing, Life Storage shareholders are expected to own approximately 35% of the combined company.
  • The investigation concerns whether Life Storage and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Life Storage shareholders; (2) determine whether Extra Space is underpaying for Life Storage; and (3) disclose all material information necessary for Life Storage shareholders to adequately assess and value the merger consideration.
  • On behalf of Life Storage shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

NEXT Life Sciences Announces Launch of Plan A™ Birth Control for Men

Retrieved on: 
Wednesday, March 22, 2023
Male, Innovation Pavilion, Woman, Child, LSI, NEXT, Growth, Astoria, Birth control

HUNTINGTON BEACH, Calif., March 22, 2023 /PRNewswire/ -- Today, NEXT Life Sciences, Inc. (NEXT) announced its plans to bring a new contraceptive product for men to market, Plan A™. NEXT is developing Plan A™ to be a safe, effective, fully reversible birth control solution for men.

Key Points: 
  • NEXT is developing Plan A™ to be a safe, effective, fully reversible birth control solution for men.
  • In connection with the launch of A™, NEXT Life Sciences, Inc. is participating in LSI's 2023 Emerging Medtech Summit in Dana Point, California (LSI USA '23).
  • "Plan A™ has the promise of revolutionize birth control – and NEXT is ready to make the promise of Plan A™ a reality."
  • "We're thrilled to welcome NEXT to LSI USA '23 and to showcase the launch of Plan A™ for male birth control," said Scott Pantel, CEO of LSI.

Acrometa to Expand to Thailand through MOU with Waste Management Company on Construction and Operation of Laboratory

Retrieved on: 
Tuesday, March 21, 2023
Health care, Research, Certification, MOU, LSI, Engineering, Municipal solid waste, Growth, Letter, Laboratory, Medtech, SME, Fine chemical, Lease, Airline, Renewable energy, Biopharma LLC, Agricultural technology, Biotechnology

It owns and operates one of Thailand's largest landfills and requires a laboratory in Thailand ("Laboratory") for the testing and certification of solid waste and sludge to ensure proper treatment of any hazardous materials.

Key Points: 
  • It owns and operates one of Thailand's largest landfills and requires a laboratory in Thailand ("Laboratory") for the testing and certification of solid waste and sludge to ensure proper treatment of any hazardous materials.
  • The MOU states the intention by the parties to jointly discuss and negotiate definitive agreements on:
    3.
  • Opportunities for ACROMETA and/or its subsidiaries to participate as a joint venture partner in the ownership of the Laboratory.
  • For a reference on ACROMETA's controlled environments engineering business, newly-acquired co-working laboratory and its Future Economy + Synergy growth strategy please see: https://www.investor-one.com/editorial/22635-ACROMETA-Future-Economy--Sy...

Veranex Joins Industry Leaders as a Sponsor for the Stanford Byers Center for Biodesign

Retrieved on: 
Monday, March 20, 2023
Science, Biotechnology, Research, General Health, Health, Health Technology, University, Education, Senior, Engineering, The Biodesign Institute, Stanford University, EVP, Policy, Connected, PST, Stanford University School of Medicine, Student, LSI, Faculty, Biological engineering, Digital, Ecosystem, Management, Medicine

Veranex , the only truly comprehensive, global, tech-enabled service provider dedicated to the medtech industry, today announced that it has joined industry leaders as corporate sponsors for the Stanford Byers Center for Biodesign .

Key Points: 
  • Veranex , the only truly comprehensive, global, tech-enabled service provider dedicated to the medtech industry, today announced that it has joined industry leaders as corporate sponsors for the Stanford Byers Center for Biodesign .
  • Stanford Biodesign trains and supports students, fellows, faculty, and global executives in healthcare technology innovation.
  • Veranex is the first medtech innovation solutions firm to sponsor the program.
  • “We’re honored to join industry leaders in supporting Stanford Biodesign because we share their commitment to innovation education and achieving the extraordinary,” said Pat Donnelly, Chairman and CEO of Veranex.

EQS-News: TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023

Retrieved on: 
Friday, March 17, 2023
Magnet, Infection, CE, TVM, Radiation, PFC, Therapy, Partnership, Workflow, Pathology, CAD, General partnership, Sleep apnea, Partner (business rank), Science, Creativity, II, Knee pain, Thrombosis, Motion, Phlebitis, Investment, Risk, Patient, LSI, Growth, Eli Lilly and Company, Eye injury, AI, FDA, Health Canada, Summit, Knee, Pharmaceutical industry, Renewable energy, Medical imaging, Medical device, EU

Montreal, Canada / Munich, Germany – 17 March 2023 – TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation, today announced that Dr. Luc Marengère, Managing Partner, and Dr. Sascha Berger, General Partner of TVM, will participate in the upcoming LSI USA ’23 Emerging Medtech Summit 2023, which brings together leading innovators, active investors and committed strategics from the medtech industry to partner and build next-generation healthcare technologies.

Key Points: 
  • Montreal, Canada / Munich, Germany – 17 March 2023 – TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation, today announced that Dr. Luc Marengère, Managing Partner, and Dr. Sascha Berger, General Partner of TVM, will participate in the upcoming LSI USA ’23 Emerging Medtech Summit 2023, which brings together leading innovators, active investors and committed strategics from the medtech industry to partner and build next-generation healthcare technologies.
  • The conference will take place March 20-23, 2023, in Dana Point, California, USA.
  • “Medtech innovation plays a pivotal role in the healthcare ecosystem and has the potential to revolutionize the industry by improving patient outcomes, increasing efficiency, and reducing costs.
  • One key component of our strategy is to invest in disruptive, breakthrough, commercial-stage technologies that map essential future trends and significantly transform current standard-of-care.

TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023

Retrieved on: 
Friday, March 17, 2023
Magnet, Infection, CE, TVM, Radiation, PFC, Therapy, Partnership, Workflow, Pathology, CAD, General partnership, Sleep apnea, Partner (business rank), Science, Creativity, II, Knee pain, Thrombosis, Motion, Phlebitis, Investment, Risk, Patient, LSI, Growth, Eli Lilly and Company, Eye injury, AI, FDA, Health Canada, Summit, Knee, Pharmaceutical industry, Renewable energy, Medical imaging, Medical device, EU

MONTREAL and MUNICH, Germany, March 17, 2023 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation, today announced that Dr. Luc Marengère, Managing Partner, and Dr. Sascha Berger, General Partner of TVM, will participate in the upcoming LSI USA ’23 Emerging Medtech Summit 2023, which brings together leading innovators, active investors and committed strategics from the medtech industry to partner and build next-generation healthcare technologies.

Key Points: 
  • MONTREAL and MUNICH, Germany, March 17, 2023 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation, today announced that Dr. Luc Marengère, Managing Partner, and Dr. Sascha Berger, General Partner of TVM, will participate in the upcoming LSI USA ’23 Emerging Medtech Summit 2023, which brings together leading innovators, active investors and committed strategics from the medtech industry to partner and build next-generation healthcare technologies.
  • The conference will take place March 20-23, 2023, in Dana Point, California, USA.
  • “Medtech innovation plays a pivotal role in the healthcare ecosystem and has the potential to revolutionize the industry by improving patient outcomes, increasing efficiency, and reducing costs.
  • One key component of our strategy is to invest in disruptive, breakthrough, commercial-stage technologies that map essential future trends and significantly transform current standard-of-care.

Caira Surgical to Present their Radar Surgical Tracking Technology for Joint Replacement Surgery at LSI USA ’23 Emerging Medtech Summit

Retrieved on: 
Thursday, March 16, 2023
Robotics, Workflow, Surgeon, Orthopedic surgery, International Society for Technology in Education, LSI, Abdominal ultrasonography, Hospital, Club, Caira, TKA, Patient, TKR, NYU Langone Health, Associate, Radar, International Society, DANA, Reece Caira, Hearing, Medical device, Arthroplasty

The company will also introduce investors and strategics to its first product – the Caira Radar Navigation System for Total Knee Replacement (TKR).

Key Points: 
  • The company will also introduce investors and strategics to its first product – the Caira Radar Navigation System for Total Knee Replacement (TKR).
  • The Caira TKA Radar Navigation System is the first sub-millimeter accurate radar tracking system for orthopedic surgery and offers significant improvements over the high-cost, large-footprint and invasive surgical hardware offered by incumbent surgical navigation and robotic systems.
  • “The Caira TKA Radar Navigation System addresses each of these shortcomings to truly revolutionize orthopedic surgery,” said Caira Surgical Chief Executive Officer Jon Greenwald.
  • Those attending the Emerging Medtech Summit who are interested in scheduling a one-on-one meeting with Caira Surgical senior leadership can do so by emailing [email protected] .

Avail Medsystems as Keynote at the LSI USA 2023 Emerging Medtech Summit

Retrieved on: 
Thursday, March 16, 2023
Medtech, Robotics, Digital, Health, Johnson & Johnson, LSI, Daniel, Intuitive Surgical, Physician, OR, Evolution, Medical device

SANTA CLARA, Calif., March 16, 2023 /PRNewswire/ -- Avail, the digital hub of the operating room (OR) enabling the medical technology (MedTech) and healthcare industries to work smarter together to advance patient care, announced today that Daniel Hawkins, CEO of Avail Medsystems, will participate in a keynote panel session at Life Science Intelligence's (LSI) Emerging MedTech Summit USA 2023. Daniel will be alongside Frederic Moll, M.D., current Chief Development Officer at Johnson & Johnson and widely recognized as "the father of robotic surgery." The two will discuss the Evolution of the Digital Operating Room, and how a platform in the OR is needed to enable the digital transformation to extend beyond robotics.

Key Points: 
  • Keynote Panel Session, March 22, 2023, at 8:05am (Track 2) in Dana Point, California
    SANTA CLARA, Calif., March 16, 2023 /PRNewswire/ -- Avail, the digital hub of the operating room (OR) enabling the medical technology (MedTech) and healthcare industries to work smarter together to advance patient care, announced today that Daniel Hawkins, CEO of Avail Medsystems, will participate in a keynote panel session at Life Science Intelligence's (LSI) Emerging MedTech Summit USA 2023.
  • During the LSI panel discussion, the two will discuss the possibilities of enhanced clinical capabilities when the operating room digitizes beyond robotics.
  • Avail is a complete telepresence system and is built on a foundation of purpose-built hardware placed in facilities without capital cost.
  • Fred and I look forward to sharing our thoughts and observations on these important topics at this year's Emerging MedTech Summit and appreciate LSI inviting us to participate in the event."